Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olof Andersson

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
European Urology|June 15, 2010
Homogeneous prostate cancer mortality in the Nordic countries over four decadesMara S Meyer, Lorelei A Mucci, Swen-Olof Andersson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 18, 2004
Properties of recombinant human plasma procarboxypeptidase U produced in mammalian and insect cellsMats Strömqvist, Lennart Hansson, Jan-Olof Andersson, et al.
The Journal of Nutrition|October 21, 2011
Nuclear magnetic resonance-based metabolomics enable detection of the effects of a whole grain rye and rye bran diet on the metabolic profile of plasma in prostate cancer patientsAli A Moazzami, Jie-Xian Zhang, Afaf Kamal-Eldin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 9, 2012
CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancerSabina Davidsson, Anna-Lena Ohlson, Swen-Olof Andersson, et al.
The American Journal of Clinical Nutrition|July 3, 2009
One-carbon metabolism-related nutrients and prostate cancer survivalJulie L Kasperzyk, Katja Fall, Lorelei A Mucci, et al.
Scandinavian Journal of Urology and Nephrology|January 27, 2011
Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4)Swen-Olof Andersson, Ove Andrén, Johan Lyth, et al.
Cancer Causes & Control : CCC|May 25, 2013
Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden StudyKathryn M Wilson, Katarina Bälter, Elisabeth Möller, et al.
Frontiers in Immunology|June 20, 2022
A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia GravisKonstantinos Lazaridis, Maria Fernandez-Santoscoy, Vasiliki Baltatzidou, et al.
Carcinogenesis|June 9, 2017
Cholesterol uptake and regulation in high-grade and lethal prostate cancersKonrad H Stopsack, Travis A Gerke, Ove Andrén, et al.
Psychosomatic Medicine|March 27, 2009
Cultural participation and health: a randomized controlled trial among medical care staffLars Olov Bygren, Gösta Weissglas, Britt-Maj Wikström, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
European Urology|June 15, 2010
Homogeneous prostate cancer mortality in the Nordic countries over four decadesMara S Meyer, Lorelei A Mucci, Swen-Olof Andersson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 18, 2004
Properties of recombinant human plasma procarboxypeptidase U produced in mammalian and insect cellsMats Strömqvist, Lennart Hansson, Jan-Olof Andersson, et al.
The Journal of Nutrition|October 21, 2011
Nuclear magnetic resonance-based metabolomics enable detection of the effects of a whole grain rye and rye bran diet on the metabolic profile of plasma in prostate cancer patientsAli A Moazzami, Jie-Xian Zhang, Afaf Kamal-Eldin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 9, 2012
CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancerSabina Davidsson, Anna-Lena Ohlson, Swen-Olof Andersson, et al.
The American Journal of Clinical Nutrition|July 3, 2009
One-carbon metabolism-related nutrients and prostate cancer survivalJulie L Kasperzyk, Katja Fall, Lorelei A Mucci, et al.
Scandinavian Journal of Urology and Nephrology|January 27, 2011
Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4)Swen-Olof Andersson, Ove Andrén, Johan Lyth, et al.
Cancer Causes & Control : CCC|May 25, 2013
Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden StudyKathryn M Wilson, Katarina Bälter, Elisabeth Möller, et al.
Frontiers in Immunology|June 20, 2022
A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia GravisKonstantinos Lazaridis, Maria Fernandez-Santoscoy, Vasiliki Baltatzidou, et al.
Carcinogenesis|June 9, 2017
Cholesterol uptake and regulation in high-grade and lethal prostate cancersKonrad H Stopsack, Travis A Gerke, Ove Andrén, et al.
Psychosomatic Medicine|March 27, 2009
Cultural participation and health: a randomized controlled trial among medical care staffLars Olov Bygren, Gösta Weissglas, Britt-Maj Wikström, et al.
Pageof 12